Treatment of fluoride-containing wastewater

US11286189B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11286189-B2
Application numberUS-201816770901-A
CountryUS
Kind codeB2
Filing dateNov 30, 2018
Priority dateDec 6, 2017
Publication dateMar 29, 2022
Grant dateMar 29, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a method for treating fluoride-containing, in particular HF containing wastewater to remove fluoride and to a corresponding apparatus. In the new method calcium carbonate is reacted in a reaction step at an acidic pH≤4 with the fluoride in the wastewater to form calcium fluoride particles. Then, in a subsequent filtration step said calcium fluoride particles are separated by a porous membrane from the treated wastewater. The inventive apparatus comprises at least one reaction container/tank for reacting calcium carbonate at an acidic pH≤4 with fluoride in the wastewater to form calcium fluoride particles, as well as at least one porous membrane, in particular at least one porous ceramic membrane for separating calcium fluoride particles from the treated wastewater in a filtration step.

First claim

Opening claim text (preview).

The invention claimed is: 1. Method for treating HF-containing wastewater to remove fluoride in a crystalline process, wherein at an acidic pH≤4 calcium carbonate (CaCO 3 ) is reacted in a reaction step with the fluoride in the wastewater to form crystalline calcium fluoride (CaF 2 ) particles, and in a subsequent filtration step said CaF 2 crystalline particles are separated by a porous ceramic membrane from the wastewater, the CaCO 3 in the process performing three distinct functions: (1) neutralization of acidity by carbonate; (2) providing calcium for CaF 2 crystallization; and (3) providing seed material for crystallization. 2. Method according to claim 1 characterized by a settling step before said filtration step, wherein at least a part of said CaF 2 particles formed in said reaction step are allowed to settle. 3. Method according to claim 1 , characterized in that said membrane is a microfiltration membrane with a cutoff from about 0.1 μm to about 1 μm. 4. Method according to claim 1 , characterized in that said ceramic membrane is made from aluminium oxide (Al 2 O 3 ), titanium dioxide (TiO 2 ), zirconium dioxide (ZrO 2 ), or silicon carbide (SiC). 5. Method according to claim 1 , characterized in that CaCO 3 is reacted with the fluoride at an acidic pH≤3.5. 6. Method according to claim 1 , characterized in that the CaCO 3 is introduced to the wastewater as a powder with an average particle size≤0.1 mm. 7. Method according to claim 1 , characterized in that CaCO 3 is present as a slurry. 8. Method according to claim 1 , characterized in that CaCO 3 is used in excess to the fluoride content of the wastewater at a CaCO 3 /fluoride mass ratio of 2.6 to 5. 9. Method according to claim 8 , characterized in that the wastewater further includes phosphoric acid, and the method further including, after the reaction step, adding alkalinity to increase the pH to over 7.5, to fully precipitate phosphates. 10. Method according to claim 1 , characterized in that CaCO 3 is reacted with the fluoride for a reaction time of from 20 minutes to 40 minutes. 11. Method according to claim 10 , characterized in that the wastewater further includes phosphoric acid, and the method further including adding alkalinity to increase the pH to over 7.5, to fully precipitate phosphates. 12. Method according to claim 1 , characterized in that the wastewater further includes phosphoric acid, and the method further including, after the reaction step, adding alkalinity to increase the pH to over 7.5, to fully precipitate phosphates. 13. Method according to claim 12 , characterized in that the addition of alkalinity raises the pH to over 8.0.

Assignees

Inventors

Classifications

  • Separation means, e.g. membranes inside the reactor · CPC title

  • C02F9/00Primary

    Multistage treatment of water, waste water or sewage · CPC title

  • Fluorine; Hydrogen fluoride · CPC title

  • C02F1/583Primary

    by removing fluoride or fluorine compounds · CPC title

  • Chemical, physical or physico-chemical processes in general; Their relevant apparatus · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11286189B2 cover?
The invention relates to a method for treating fluoride-containing, in particular HF containing wastewater to remove fluoride and to a corresponding apparatus. In the new method calcium carbonate is reacted in a reaction step at an acidic pH≤4 with the fluoride in the wastewater to form calcium fluoride particles. Then, in a subsequent filtration step said calcium fluoride particles are separat…
Who is the assignee on this patent?
Ovivo Inc
What technology area does this patent fall under?
Primary CPC classification C02F9/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).